April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Comparison Study Of The IOP Reduction Efficacy And Safety Between Latanoprost And Tafluprost In Japanese Normal Tension Glaucoma Patients
Author Affiliations & Notes
  • Kaori Tada
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
    Opthalomology, Saiseikai Shigaken Hospital, Ritto, Japan
  • Yoko Ikeda
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Kazuhiko Mori
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Morio Ueno
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Kojiro Imai
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Shigeru Kinoshita
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Shigeru Kinoshita
    Ophalmology, Kyoto Prefecture Univercity of medecine, Kyoto, Japan
  • Footnotes
    Commercial Relationships  Kaori Tada, None; Yoko Ikeda, None; Kazuhiko Mori, None; Morio Ueno, None; Kojiro Imai, None; Shigeru Kinoshita, None; Shigeru Kinoshita, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 226. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kaori Tada, Yoko Ikeda, Kazuhiko Mori, Morio Ueno, Kojiro Imai, Shigeru Kinoshita, Shigeru Kinoshita; Comparison Study Of The IOP Reduction Efficacy And Safety Between Latanoprost And Tafluprost In Japanese Normal Tension Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):226.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate and compare the intraocular pressure (IOP) reduction efficacy and safety between latanoprost (Lat) and tafluprost (Taf) in Japanese normal tension glaucoma patients, prospectively.

Methods: : We enrolled 25 Japanese normal tension glaucoma (NTG) patients who had used Lat monotherapy for more than 4 weeks, and divided into the two groups randomly; Lat to Taf group (LT group) and Taf to Lat group (TL group). At the beginning, both groups were switched from initial Lat to Lat or Taf for 12 weeks, and then switched over each drug (crossover) and used for 12 more weeks. Written informed consent was obtained from all participants. We evaluated IOP at 0, 4, 12, 16, and 24 weeks from the first switching, respectively. We also evaluated the conjunctival injection score (0-3 grade), corneal epitheliopathy score (area density classification; AD score), and the changes of eyelashes and pigmentation of eyelids or irises at 12 and 24 weeks, respectively.

Results: : The mean IOP of TL group (13 eyes) were 11.1, 10.8, and 10.4 mmHg, while that of LT group (12 eyes) were 10.4, 10.8, and 11.1 mmHg at 0, 12 and 24 weeks respectively. There were no significant differences between two groups and intra-group comparisons. The conjunctival injection score were 1.0±0.4 at baseline, 1.0±0.5 (Taf group) and 0.9±0.5 (Lat group) at 12 weeks. The corneal AD score (total score of area and density grade) were 0.9±1.2 at baseline, 0.8±1.1 (Taf) and 0.6±1.1 (Lat) at 12 weeks. There were no significant differences between the two drugs. The changes of eye lashes, pigmentation of eyelids and irises showed similar expressions in both groups.

Conclusions: : Tafluprost and latanoprost are considered to have the equivalent efficacy and safety in the Japanese normal tension glaucoma patients.

Clinical Trial: : Umin-CTR, UMIN000002017

Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×